Artiva Biotherapeutics (ARTV) Other Gross PP&E Adjustments (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with $14.9 million as the latest value for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 23.53% year-over-year to $14.9 million; the TTM value through Dec 2025 reached $14.9 million, up 23.53%, while the annual FY2025 figure was $14.9 million, 23.53% up from the prior year.
- Other Gross PP&E Adjustments hit $14.9 million in Q4 2025 for Artiva Biotherapeutics, up from $3.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $14.9 million in Q4 2025 and bottomed at -$4.9 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 3 years is $6.1 million, with a median of $7.7 million recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments skyrocketed 344.6% in 2024 and then plummeted 70.38% in 2025.
- Artiva Biotherapeutics' Other Gross PP&E Adjustments stood at -$4.9 million in 2023, then surged by 344.6% to $12.0 million in 2024, then increased by 23.53% to $14.9 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $14.9 million, $3.5 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.